• Universal Health Services Buys Talkspace for $835 Million

    by | Mar 9, 2026 11:40 am | eHealth

    Universal Health Services (UHS) has entered into a definitive agreement to acquire Talkspace, Inc. for $5.25 per share. The enterprise value for the transaction is approximately $835 million, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility. Talkspace is a telebehavioral healthcare company. Its... Read More »

  • Agilent to Acquire Biocare Medical

    by | Mar 9, 2026 11:38 am | Laboratories, MRI & Dialysis

    Agilent Technologies announced that it has entered into a definitive agreement to acquire Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners LLP. The all-cash transaction is valued at $950 million. Biocare Medical is a leading provider of immunohistochemistry (IHC) instrumentation, as well as a full range of... Read More »

  • Integration Health Buys Perfusion Life

    by | Mar 6, 2026 3:19 pm | Healthcare Staffing

    Integration Health is deepening its perfusion staffing capabilities with the acquisition of Perfusion Life in Raleigh, North Carolina. Perfusion Life is a perfusion staffing network connecting hospitals with credentialed perfusionists across the United States and Canada. Perfusion Life has cultivated a network of more than 1,300 credentialed... Read More »

  • CBRE Advises on Sale of Elk Grove Village Medical Campus

    by | Mar 5, 2026 10:35 am | Medical Outpatient Buildings

    CBRE has facilitated the sale of the Elk Grove Village Medical Campus, according to a March 4 press release. The property was sold to Casa Avore, a private capital group specializing in healthcare real estate. Elk Grove Village Medical Campus is a 52,126-square-foot campus with four medical outpatient buildings (MOBs) located in Elk Grove... Read More »

  • Health Recovery Solutions Acquires Remote Patient Monitoring Company Rimidi

    by | Mar 5, 2026 10:34 am | eHealth

    Health Recovery Solutions (HRS) announced on March 4 its acquisition of Atlanta, Georgia-based Rimidi. Rimidi is a chronic disease management and remote monitoring company with deep roots in diabetes and cardiometabolic management. The company supports healthcare providers with electronic health record-integrated software, services and connected... Read More »
BGH Capital ‌Acquires ⁠Aspen Pharmacare Assets for $1.58 Billion 

BGH Capital ‌Acquires ⁠Aspen Pharmacare Assets for $1.58 Billion 

by | Dec 29, 2025 2:34 pm | Pharmaceuticals

On December 29, BGH Capital announced that it was purchasing select assets from Aspen Pharmacare. The purchase price is A$2.37 billion (more than USD $1.585 billion).  The assets include Aspen’s Asia Pacific assets (Hong Kong, Taiwan, Malaysia and Philippines), excluding China. The assets constituted 18% of Aspen’s total revenue and 26% of its core profit for ‌the year ⁠ended 30 June 2025, according to the company.  Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. It has approximately 9,100 employees at 69 established offices in more than 50 countries. It also operates 23 manufacturing... Read More »
Samsung Biologics America Acquires Human Genome Sciences 

Samsung Biologics America Acquires Human Genome Sciences 

by | Dec 22, 2025 3:02 pm | Pharmaceuticals

On December 21, Samsung Biologics announced that its portfolio company, Samsung Biologics America (SBA), will acquire a 100% stake in Human Genome Sciences from GSK. Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, the purchase price is $280 million.  Human Genome Sciences operates as a biopharmaceutical company in the United States. Its principal products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax.  Samsung Biologics is a leading contract development and manufacturing organization, offering end-to-end integrated services that range from late discovery to commercial manufacturing. SBA is Samsung... Read More »
BGH Capital ‌Acquires ⁠Aspen Pharmacare Assets for $1.58 Billion 

Azurity Pharmaceuticals Acquires Sebela Assets 

by | Nov 18, 2025 3:27 pm | Pharmaceuticals

Azurity Pharmaceuticals, a portfolio company of QHP Capital, announced that it acquired select assets from Sebela Pharmaceuticals. The transaction includes two leading bowel preparation therapies for colonoscopies.  Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in gastroenterology and a focus on innovation in women’s health.  Founded in 1998, Azurity Pharmaceuticals focuses on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist. It is based in Woburn, Massachusetts.  By integrating Sebela’s bowel prep franchise,... Read More »
Axsome Therapeutics Acquires Baergic Bio 

Axsome Therapeutics Acquires Baergic Bio 

by | Nov 7, 2025 4:52 pm | Pharmaceuticals

Axsome Therapeutics reported on November 5 that it acquired Baergic Bio, Inc. from Avenue Therapeutics for $0.3 million.  Founded in December 2019, Baergic Bio is a clinical-stage pharmaceutical company that focuses on the development of a pharmaceutical product for the treatment of CNS disorders.   Axsome Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system disorders. According to its financial reports, the company reported $385.7 million in revenue for the full year 2024.  Avenue Therapeutics, a specialty pharmaceutical company, initially purchased Baergic Bio in 2022.  The transaction... Read More »
Advent International Sells Zentiva to GTCR 

Advent International Sells Zentiva to GTCR 

by | Sep 12, 2025 4:13 pm | Pharmaceuticals, Physician Medical Groups

Advent International, a private equity firm focused on buyouts of companies, announced on September 11 that it sold Zentiva to GTCR.  Zentiva is a leading European generics pharmaceutical company with a focus on developing, producing and delivering affordable medicines to more than 100 million people in more than 30 countries across Europe and beyond. Zentiva has four wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security.  Founded in 1980, GTCR is a private equity firm focused on investing in growth companies in the business and consumer services, financial services and technology, healthcare and technology and media and... Read More »
CapVest To Buy Majority Stake In STADA

CapVest To Buy Majority Stake In STADA

by | Sep 2, 2025 1:31 pm | Pharmaceuticals

CapVest Partners has signed an agreement with Bain Capital and Cinven to acquire a majority stake in STADA Arzneimittel AG. STADA Arzneimittel manufactures and distributes specialty pharmaceuticals and non-prescription consumer health products. Located in Bad Vilbel, Germany, STADA has evolved from a traditional generics business into a diversified global healthcare platform since its acquisition by Bain Capital and Cinven in 2017. CapVest Partners is an established European mid-market private equity firm focused on acquiring market leading companies supplying essential products and services. CapVest was formed in 1999 and is based in London. The lead financial advisors to CapVest were... Read More »